The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Disease modifying anti‐rheumatic drugs in people with cystic fibrosis‐related arthritis
|
---|---|
Published in |
Cochrane database of systematic reviews, September 2012
|
DOI | 10.1002/14651858.cd007336.pub3 |
Pubmed ID | |
Authors |
Judith Thornton, Satyapal Rangaraj |
Abstract |
Arthritis remains a relatively infrequent complication of cystic fibrosis, but is a cause of significant morbidity when it does occur. Two distinct types of arthritis are described in cystic fibrosis: cystic fibrosis-related arthropathy and hypertrophic osteoarthropathy. Management of arthritis in people with cystic fibrosis is uncertain and complex because of the underlying disease and its treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 115 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 12% |
Student > Master | 13 | 11% |
Researcher | 11 | 9% |
Student > Doctoral Student | 9 | 8% |
Student > Bachelor | 9 | 8% |
Other | 23 | 20% |
Unknown | 37 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 42 | 36% |
Psychology | 7 | 6% |
Nursing and Health Professions | 7 | 6% |
Unspecified | 5 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Other | 8 | 7% |
Unknown | 42 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2012.
All research outputs
#22,830,981
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#11,281
of 11,842 outputs
Outputs of similar age
#168,630
of 187,469 outputs
Outputs of similar age from Cochrane database of systematic reviews
#217
of 224 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,469 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.